Health Care: Drugs

Redhill Biopharma Ltd (RDHL: NASDAQ)

$9.85 -0.1398 | -1.4%
05/26/17 - 04:00 PM ET
Company Income Statement
Dec 2016 Dec 2015 Dec 2014 Dec 2013
Sales 101.00K 3.00K 7.01M 12.00K
Cost of Sales 0.00 0.00 1.02M 0.00
Gross Operating Profit 101.00K 3.00K 5.99M 12.00K
Selling, General, and Administrative Expenses 5.40M 4.13M 4.01M 2.68M
Research & Development 25.24M 17.77M 12.70M 8.10M
Operating Income before D & A (EBITDA) -30.54M -21.90M -10.72M -10.77M
Depreciation & Amortization 44.00K 36.00K 27.00K 24.00K
Interest Income 282.00K 236.00K 119.00K 30.00K
Other Income - Net 891.00K 676.00K -183.00K 114.00K
Special Income / Charges 0.00 -100.00K 100.00K 0.00
Total Income Before Interest Expenses (EBIT) -29.41M -21.13M -10.71M -10.65M
Interest Expense 0.00 0.00 0.00 0.00
Pre-Tax Income -29.41M -21.13M -10.71M -10.65M
Income Taxes 0.00 0.00 0.00 0.00
Minority Interest 0.00 0.00 0.00 0.00
Net Income From Continuing Operations -29.37M -21.09M -10.71M -10.63M
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations -29.37M -21.09M -10.71M -10.63M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income -29.37M -21.09M -10.71M -10.63M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-29.37M -20.99M -10.81M -10.63M
Preferred Dividends
Net Income Available To Common -29.37M -21.09M -10.71M -10.63M
Basic EPS from Continuing Ops. -2.30 -1.90 -1.20 -1.70
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations -2.30 -1.90 -1.20 -1.70
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total -2.30 -1.90 -1.20 -1.70
Basic Normalized Net Income/Share -2.30 -1.89 -1.21 -1.70
EPS fr Continuing Ops. -2.40 -1.90 -1.30 -1.70
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. -2.40 -1.90 -1.30 -1.70
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total -2.40 -1.90 -1.30 -1.70
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-2.40 -1.89 -1.31 -1.70
Dividends Paid per Share 0.00 0.00 0.00 0.00

Portfolios with RDHL

  • Portfolio NameUser Type

Latest RDHL Headlines from TheStreet

More Financial News for RDHL

Press Releases for RDHL

See All Press Releases
brokerage partners
watch thestreet tv
No Videos Found
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter